Dicot Pharma AbOMXSTO: DICOT

Dicot Pharma Signs Agreement With CRO Ahead Of Phase 2B Study With Lib-01

· Issued by Dicot Pharma Ab

Dicot Pharma AB OMXSTO:DICOT:

  • SIGNS AGREEMENT WITH CRO AHEAD OF PHASE 2B STUDY WITH LIB-01

  • STUDY WILL BE CONDUCTED IN US AND EUROPE AND IS EXPECTED TO START DURING SECOND HALF OF 2026.